IP Library Granted Patent US 8,147,862
Granted Patent B2
US 8,147,862 · App. 12/355,569 · Granted Apr 3, 2012

Highly mineralized osteogenic sponge compositions and uses thereof

Assignee: Warsaw Orthopedic, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,147,862
App. No.
12/355,569
Granted
Apr 3, 2012
Kind
B2
Abstract

Osteogenic sponge compositions having enhanced osteoinductive properties for use in bone repair are described. The compositions include a quickly resorbable porous carrier, a more slowly resorbed mineral scaffold and an osteogenic factor, preferably a bone morphogenetic protein. The compositions enable increased osteoinductive activity while retaining a reliable scaffold for the formation of new bone at an implant site. Methods for therapeutic use of the compositions are also described.

Claims (26)

1. An osteogenic sponge composition useful for the induction of new bone growth in a mammal, comprising:

a resorbable sponge matrix material comprising collagen and a particulate biocompatible mineral comprising a ceramic material embedded within said resorbable sponge matrix material, the resorbable sponge matrix material being three-dimensionally stable but flexible and comprising 95% to 99% by weight of the particulate biocompatible mineral; and

an osteogenic factor, comprising a bone morphogenic protein, said osteogenic factor incorporated in said sponge matrix material in an amount that causes resorption of said sponge matrix material in a mammal, wherein the resorbable sponge matrix material provides a scaffold for bone ingrowth in the presence of said osteogenic factor.

2. The osteogenic sponge composition of claim 1 , wherein said resorbable sponge matrix comprises 1% to 3% by weight of collagen and 97% to 99% by weight of the particulate biocompatible mineral.

3. The osteogenic sponge composition of claim 2 , wherein said osteogenic sponge composition exhibits sufficient flexibility to be rolled up when hydrated.

4. The osteogenic sponge composition of claim 3 , wherein said particulate biocompatible mineral is resorbed more slowly than the collagen when said osteogenic sponge composition is implanted in said mammal.

5. The osteogenic sponge composition of claim 1 , wherein said particulate biocompatible mineral is selected from the group consisting of bone particles and biocompatible synthetic calcium phosphate ceramics.

6. The osteogenic sponge composition of claim 5 , wherein said particulate biocompatible mineral comprises biphasic calcium phosphate.

7. The osteogenic sponge composition of claim 6 , wherein said biphasic calcium phosphate has a porosity of at least about 50%.

8. The osteogenic sponge composition of claim 7 , wherein said particulate biocompatible mineral includes bone particles.

9. The osteogenic sponge composition of claim 8 , wherein said bone particles are cortical bone particles.

10. The osteogenic sponge composition of claim 1 , wherein said particulate biocompatible mineral comprises 15% by weight hydroxyapatite and 85% by weight tricalcium phosphate based on the total weight of said particulate biocompatible mineral embedded within said resorbable sponge matrix material and said resorbable sponge matrix material comprises 3% by weight collagen.

11. The osteogenic sponge composition of claim 1 , wherein said particulate biocompatible mineral has an average particle size in the range of about 0.5 mm to about 5.0 mm.

12. The osteogenic sponge composition of claim 1 , wherein said particulate biocompatible mineral has an average particle size in the range of about 1 mm to about 2 mm.

13. The osteogenic sponge composition of claim 1 , wherein said particulate biocompatible mineral comprises biphasic calcium phosphate having tricalcium phosphate to hydroxyapatite weight of about 50:50 to about 95.5.

14. The osteogenic sponge composition of claim 1 , wherein said bone morphogenetic protein is a recombinant human protein.

15. The osteogenic sponge composition of claim 14 , wherein said bone morphogenetic protein is BMP-2 or BMP-7.

16. The osteogenic sponge composition of claim 15 , further comprising an osteogenic enhancing factor selected from the group consisting of autographic bone marrow, allographic bone marrow, transforming growth factor β, fibroblast growth factor, platelet-derived growth factor, insulin-like growth factor, microglobulin β, and steroids.

17. An osteogenic sponge composition comprising:

a highly mineralized sponge implant device, said device comprising a resorbable sponge matrix material formed of lyophilized collagen and having a particulate biocompatible mineral comprising a ceramic material embedded within said resorbable sponge matrix material, the resorbable sponge matrix material being three-dimensionally stable but flexible and comprising 95% to 99% by weight of the particulate biocompatible mineral;

an osteogenic factor comprising bone morphogenic protein-2 that stimulates osteoblasts and osteoclasts, said osteogenic factor incorporated in said device in an amount that causes an increased rate of resorption of said sponge matrix material in a primate; wherein said particulate biocompatible mineral is resorbed more slowly than said resorbable sponge matrix material, so as to provide a scaffold for bone ingrowth that remains in the primate after said resorbable sponge matrix is resorbed.

18. The sponge composition of claim 17 wherein the primate is a human.

19. A method for inducing bone growth in a primate, comprising:

(a) providing an osteogenic sponge composition comprising:

a resorbable sponge matrix material comprising collagen and a particulate biocompatible mineral comprising a ceramic material embedded within said matrix material, the resorbable sponge matrix material being three-dimensionally stable but flexible and comprising 95% to 99% by weight of the particulate biocompatible mineral; an osteogenic factor comprising a bone morphogenic protein that stimulates osteoblasts and osteoclasts, said osteogenic factor incorporated in said sponge matrix material in an amount that causes resorption of said sponge matrix material in the primate; wherein the resorbable sponge matrix material provides a scaffold for bone ingrowth in the presence of said osteogenic factor; and

(b) implanting said osteogenic sponge composition in an area in which bone growth is desired in the primate, said osteogenic sponge composition providing a scaffold for a duration sufficient for osteoid ingrowth through an area in which said osteogenic sponge composition is implanted.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2011
From: MCKAY, WILLIAM F.
To: SDGI HOLDINGS, INC.
Reel/Frame 027415/0902 →
MERGER Recorded Dec 20, 2011
From: SDGI HOLDINGS, INC.
To: WARSAW ORTHOPEDIC, INC.
Reel/Frame 027416/0039 →
Continuity (4)
Continuation 09923116 · Aug 6, 2001
Continuation PCTUS0003043 · Feb 4, 2000
Provisional Application 60118615 · Feb 4, 1999
Related Publication 20090196904A1 · Aug 6, 2009